Keywords: alliance, pharma, starts, ph, iii, trial, apl202

Alliance Pharma starts Ph III trial for APL202

Article | 17 January 2005

Print This

Alliance Pharma of the UK says it has commenced its registration trial program for APL202 (misoprostol), which is under investigation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in